Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2018

PFO Closure to Prevent Recurrent Cryptogenic Stroke

Presenter: Matthew J. Price

October 26, 2018

Presentation SIF 2017

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Presenter: James A. Goldstein

March 09, 2017

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

Presentation

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

Presenter: Pablo Rengifo

October 29, 2015

Presentation

PFO Closure Following Cryptogenic Stroke or TIA

Presenter: Mikaeil Mirzaali

July 02, 2015

Presentation

Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke

Presenter: Christopher A. Pickett

September 30, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Presentation

Predictors of Recurrent Events in Patients with Cryptogenic Stroke and PFO in the CLOSURE I Trial

Presenter: S. Elmariah

August 20, 2014

Presentation

RESPECT: Closure of Patent Foramen Ovale (PFO) vs. Medical Therapy After Cryptogenic Stroke

Presenter: John D. Carroll

March 20, 2013

Presentation TCT 2012

RESPECT: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Stroke

Presenter: John Carroll

October 25, 2012

Presentation TCT 2012

Cryptogenic Stroke vs PFO Stroke? Neurology Perspectives

Presenter: David Thaler

October 22, 2012

Presentation

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Presenter: Anthony J. Furlan

March 14, 2012

Advertisement

PFO Closure to Prevent Recurrent Cryptogenic Stroke

PFO Closure for Cryptogenic Stroke Choose your Patients Well

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

PFO Closure Following Cryptogenic Stroke or TIA

Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Predictors of Recurrent Events in Patients with Cryptogenic Stroke and PFO in the CLOSURE I Trial

RESPECT: Closure of Patent Foramen Ovale (PFO) vs. Medical Therapy After Cryptogenic Stroke

RESPECT: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Stroke

Cryptogenic Stroke vs PFO Stroke? Neurology Perspectives

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content